About Index Trending news
Analyze
Pricing
Zavante Therapeutics, Inc.

Zavante Therapeutics, Inc.

Zavante Therapeutics, Inc.

Zavante is a clinicalstage biopharmaceutical company focused on developing novel therapies to improve the outcomes of hospitalized patients.

Elsewhere

Alexa global traffic share

Latest funding Show all
Debt financing
$10,000,000
Venture capital (Series A)
$45,000,000
Employees

Team size

2
Locations
HQ
$10,000,000 Debt financing
FinSMEs

Zavante Therapeutics Receives $10M Credit Facility from Square 1 Bank

Health Funding
$45,000,000 Venture capital (Series A)
VentureWire

The Daily Startup: Zavante Raises $45 Million to Treat Deadly Infections

Funding
$10,000,000 Venture capital
MedCity News

Zavante gets $10M for CRE-treating antibiotic to enter clinic